Brief: Bioinvent Q1 Loss After Tax Widens To SEK 32.6 Million

BioInvent International AB

28/04/2020 07:10

April 28 (Reuters) - BioInvent International AB  BINV.ST :
    * Q1 NET SALES SEK 16.7 (17.4) MILLION
    * Q1 LOSS AFTER TAX SEK -32.6 (-27.8) MILLION
    * STILL EXPECT EARLY RESULTS FROM PHASE I OPEN LABEL STUDY
WITH A
COMBINATION OF BI-1206 AND RITUXIMAB FOR TREATMENT OF NHL IN H2
2020
    * TIMELINES ARE STILL SUBJECT TO POTENTIAL CHANGES AND WE
WILL
PROVIDE UPDATES AS NECESSARY

Source text for Eikon:  ID:nWkr7p9ZdX 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))